Patent details

EP2277537 Title: Neisseria meningitidis conjugate combination vaccine.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2277537
WO Application Number:
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10179806.4
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
20/06/2002
Grant date:
25/03/2015
EP Publication Date:
25/03/2015
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
25/03/2015
EP B1 Publication Date:
25/03/2015
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
30/04/2015
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
19/06/2022
Lapsed By Expiration Date:
20/06/2022
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
22/12/2021
 
 

 

Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)

Historical Applicant/holder

From:
25/03/2015
To:
22/12/2021

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)

Domicile Holder

Name:
ir. F.A. Geurts c.s.
From:
25/03/2015
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

Name:
Costantino, Paolo
Address:
53100 SIENA, Italy (IT)

Priority

Priority Patent Number:
0115176
Priority Date:
20/06/2001
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 39/095;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
25/22
Publication date:
22/06/2022
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
05/22
Publication date:
02/02/2022
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
EP3
Journal edition number:
2015/21
Publication date:
20/05/2015
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
2015/14
Publication date:
01/04/2015
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201513
Publication date:
25/03/2015
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202102715A
Date Registered:
22/12/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut 89, 1330, Rixensart, Belgium (BE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
20/05/2021
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
12/05/2015 Outgoing Correspondence Outgoing Letter 1 PDF /6/0/8/9/7/0510179806/docs/ep10179806.4_1_outgoingcorrespondence20150512.pdf
30/04/2015 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /6/0/8/9/7/0510179806/docs/ep10179806.4_0_incomingcorrespondencepaper20150430.pdf
30/04/2015 Outgoing Correspondence Outgoing Letter 1 PDF /6/0/8/9/7/0510179806/docs/ep10179806.4_2_outgoingcorrespondence20150430.pdf
30/04/2015 Claims Translated claims 3 PDF /6/0/8/9/7/0510179806/docs/ep10179806.4_3_claims20150430.pdf